UK-based distillery Collider Brew Co. introduces one of the country's pioneering adaptogen-infused, non-alcoholic beers, catering to consumers looking to reduce alcohol intake. With a 0.5% ABV, the beer incorporates adaptogens—plants and mushrooms known for stress-relieving properties—to enhance overall well-being and eliminate potential hangovers.
Available in two styles, Unwind Lager and Unwind Session Pale, the brew features Collider Brew Co's signature blend of adaptogens, British malted barley, wheat, hops, yeast, and water. Adding adaptogens like Ashwagandha, L-theanine, and Lion's Mane claim to deliver anti-anxiety and calming effects, aiding cognitive function and reducing stress.
"Collider offers drinkers delicious tasting beers with sensory, mood boosting benefits, without the hangover and negative effects from alcohol," said Harry Cooke, Pale Fox Wines co-founder.
Adaptogen-Infused British Beers
Collider Brew Co. Launches a Non-Alcoholic Beer in the UK
Trend Themes
1. Adaptogen-infused Beers - British brewery Collider Brew Co. pioneers adaptogen-infused, non-alcoholic beers to cater to health-conscious consumers.
2. Reduced Alcohol Intake - Collider Brew Co.'s non-alcoholic beers target consumers seeking to decrease their alcohol consumption.
3. Stress Relief Beers - Collider Brew Co.'s adaptogen-infused beers aim to provide stress-relieving properties and enhance overall well-being.
Industry Implications
1. Brewery - The brewery industry can explore the potential of incorporating adaptogens in their beer products to cater to health-conscious consumers.
2. Non-alcoholic Beverages - The non-alcoholic beverages industry can capitalize on the growing trend of adaptogen-infused drinks that provide stress-relief benefits.
3. Wellness - The wellness industry can tap into the market for products that promote stress relief and enhance well-being, such as adaptogen-infused beers.